143 related articles for article (PubMed ID: 2163328)
1. New Approaches Targeting the Renin-Angiotensin System: Inhibition of Brain Aminopeptidase A, ACE2 Ubiquitination, and Angiotensinogen.
Lazartigues E; Llorens-Cortes C; Danser AHJ
Can J Cardiol; 2023 Dec; 39(12):1900-1912. PubMed ID: 37348757
[TBL] [Abstract][Full Text] [Related]
2. Obese Male Mice Exposed to Early Life Stress Display Sympathetic Activation and Hypertension Independent of Circulating Angiotensin II.
Dalmasso C; Ahmed NS; Ghuneim S; Cincinelli C; Leachman JR; Giani JF; Cassis L; Loria AS
J Am Heart Assoc; 2024 Jan; 13(1):e029511. PubMed ID: 38156515
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensin II-induced hypertension in mice.
Tang K; Wang X; Zhao Y; Li X; Jiang Z; Mei S; Chen M; Ma Y; Du X; Qiao X; Sun N; Liu J; Jiang C
Sci China Life Sci; 2023 Oct; 66(10):2370-2379. PubMed ID: 36949230
[TBL] [Abstract][Full Text] [Related]
4. The intricacies of the renin-angiotensin-system in metabolic regulation.
Bruce EB; de Kloet AD
Physiol Behav; 2017 Sep; 178():157-165. PubMed ID: 27887998
[TBL] [Abstract][Full Text] [Related]
5. Modulatory Effects of the Kuwanon-Rich Fraction from Mulberry Root Bark on the Renin-Angiotensin System.
Lee JH; Kim HW; Kim SA; Ju WT; Kim SR; Kim HB; Cha IS; Kim SW; Park JW; Kang SK
Foods; 2024 May; 13(10):. PubMed ID: 38790847
[TBL] [Abstract][Full Text] [Related]
6. Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States.
Kanugula AK; Kaur J; Batra J; Ankireddypalli AR; Velagapudi R
Cureus; 2023 Jun; 15(6):e40725. PubMed ID: 37350982
[TBL] [Abstract][Full Text] [Related]
7. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
Langtry HD; Markham A
Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors. Differential use in elderly patients with hypertension.
Israili ZH; Hall WD
Drugs Aging; 1995 Nov; 7(5):355-71. PubMed ID: 8573991
[TBL] [Abstract][Full Text] [Related]
9. The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors.
Ganten D; Mullins J; Lindpaintner K
J Hum Hypertens; 1989 Jun; 3 Suppl 1():63-70. PubMed ID: 2674443
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors: mechanistic controversies.
Ujhelyi MR; Ferguson RK; Vlasses PH
Pharmacotherapy; 1989; 9(6):351-62. PubMed ID: 2559394
[TBL] [Abstract][Full Text] [Related]
11. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
[TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibitors differentially affect expression of genes of the renin-angiotensin system.
Keuneke C; Yacullo R; Sugiura M; Mall G; Metzger R; Ganten D
Clin Exp Hypertens; 1995 Apr; 17(3):551-74. PubMed ID: 7613528
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Teisman AC; Pinto YM; Buikema H; Flesch M; Böhm M; Paul M; van Gilst WH
J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
